Skip to main content
  • High Intensity Ultrasound for the Treatment of Vincristine Induced Neuropathic Pain

    Final Number:
    353

    Authors:
    Youngwon Youn BA; Ian Thomas Walling BS; Lucy Gee BS; Paul Neubauer; Lance Frith; Emery Williams; Clif Burdette PhD; Julie G. Pilitsis MD PhD

    Study Design:
    Laboratory Investigation

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2016 Annual Meeting

    Introduction: Vincristine is a commonly used chemotherapeutic agent but is associated with debilitating peripheral neuropathy that is often refractory to traditional medication (Calvetti 2015). We explore one neuromodulatory option, High Intensity Focused Ultrasound (HIFU), which may work by altering neuronal activity. Thus, we focus on the efficacy of HIFU in treating vincristine induced neuropathy (VIN) in the animal model.

    Methods: VIN rodents were created using a previously used animal model (Barzegar-Fallah 2013) and neuropathy was confirmed by mechanical and thermal testing using Von Frey Filaments (VFF), Randal-Selitto (RS), hot plate (HP), and tail flick tests (TF). The VFF and RS test are measures of innocuous and noxious mechanical thresholds respectively and the HP and TF are measures of paw and tail withdrawal times to thermal stimuli. These tests were performed before neuropathy induction, after a 2 week induction period, at 24 hours after HIFU and at 48 hours after HIFU. HIFU was applied to the L5 dorsal root ganglion of the left hind paw at three watts for two minutes.

    Results: Although we only have one animal in our HIFU group thus far, our preliminary data suggests that HIFU increases mechanical and thermal thresholds as compared to that of HIFU sham animals (n=5). Specifically, innocuous and noxious mechanical thresholds were increased as measured with the VFF and RS tests, and thermal thresholds were also increased as measured by the hot plate test at 48 hours after HIFU application. Our HIFU animal did not exhibit increased tail flick thresholds.

    Conclusions: Our preliminary data suggests that high intensity ultrasound may be an effective way to increase mechanical and thermal thresholds in vincrinstine induced neuropathy.

    Patient Care: As the first study to assess the effectiveness of HIFU in the context of chemotherapy related pain, our results may give evidence to HIFU’s potential as a new therapy for those suffering from chronic pain.

    Learning Objectives: 1) Vincristine induces neuropathy in rats by decreasing sensory thresholds 2) High intensity ultrasound increases mechanical and thermal thresholds.

    References: Barzegar-fallah A, Alimoradi H, Mehrzadi S, et al. The neuroprotective effect of tropisetron on vincristine-induced neurotoxicity. Neurotoxicology. 2014;41:1-8. Carozzi VA, Canta A, Chiorazzi A. Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?. Neurosci Lett. 2015;596:90-107. Cavaletti G, Marmiroli P. Chemotherapy-induced peripheral neurotoxicity. Curr Opin Neurol. 2015;28(5):500-7.

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy